Clinical use of antimicrobial pharmacodynamic profiles to optimise treatment outcomes in community-acquired bacterial respiratory tract infections: application to telithromycin

By Nicolau David P  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 229-235

Informa Healthcare

Access to resources Recommend Favorite

Telithromycin: a new ketolide antimicrobial for treatment of respiratory tract infections

By Yassin H.M.   Dever L.L.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 353-367

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Newer Oral Cephalosporins: Implications for Treatment of Community-Acquired Lower Respiratory Tract Infections

By Cazzola M.   Matera M.G.   Donner C.F.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 335-346

Adis International

Access to resources Recommend Favorite

What is the Place of Fluoroquinolones in the Treatment of Community-Acquired Respiratory Tract Infections?

By Momméja-Marin H.   Carbon C.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 851-853

Adis International

Access to resources Recommend Favorite

Clinical Experience in Germany of Treating Community-acquired Respiratory Infections with the New 8-Methoxyfluoroquinolone, Moxifloxacin

By Landen H   Möller M   Tillotson GS   Kubin R   Höffken G  

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 51-60

Field House Publishing

Access to resources Recommend Favorite